Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography

British Journal of Ophthalmology

Volumn 98, Issue 7, 2014, Pages 956-960

  Inoue, Maiko ^a   Arakawa, Akira ^a   Yamane, Shin ^a   Kadonosono, Kazuaki ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; CENTRAL FOVEAL THICKNESS; CLINICAL ARTICLE; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETINAL ANGIOMATOUS PROLIFERATION; RETINAL THICKNESS; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SYSTEMIC DISEASE; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; PAPILLEDEMA; RETINAL DETACHMENT; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84902381356     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304251     Document Type: Article

References (20)

1. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-34. (Pubitemid 32971350)
2. Hartnett ME, Weiter JJ, Staurenghi G, et al. Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 1996;103:2042-53. (Pubitemid 27024625)
3. Bottoni F, Massacesi A, Cigada M, et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005;123:1644-50. (Pubitemid 41785096)
4. Bressler NM. Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch Ophthalmol 2005;123:1741-3. (Pubitemid 41785112)
5. Johnson TM, Glaser BM. Focal laser ablation of retinal angiomatous proliferation. Retina 2006;26:765-72. (Pubitemid 44386098)
6. Boscia F, Furino C, Sborgia L, et al. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 2004;138:1077-9. (Pubitemid 40040042)
7. Boscia F, Parodi MB, Furino C, et al. Photodynamic therapy with vertepor fin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2006;244:1224-32. (Pubitemid 44463458)
8. Sakimoto S, Gomi F, Sakaguchi H, et al. Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 2005;139:917-18. (Pubitemid 40614784)
9. Shiragami C, Iida T, Nagayama D, et al. Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 2007;27:198-203.
10. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
11. Engelbert M, Zweifel SA, Freund KB. 'Treat and extend' dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. Retina 2009;29:1424-31.
12. Atmani K, Voigt M, Le Tien V, et al. Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration. Eye (Lond) 2010;24:1193-8.
13. McBain VA, Kumari R, Townend J, et al. Geographic atrophy in retinal angiomatous proliferation. Retina 2011;31:1043-52.
14. Gharbiya M, Parisi F, Cruciani F, et al. Intravitreal anti-vascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long-term functional and anatomical results using a modified PrONTO-style regimen. Retina 2014;34(2):298-305.
15. Sunness JS, Ziegler MD, Applegate CA. Issues in quantifying atrophic macular disease using retinal autofluorescence. Retina 2006;26:666-72. (Pubitemid 44620368)
16. Hemeida TS, Keane PA, Dustin L, et al. Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. Br J Ophthalmol 2010;94:701-5.
17. Kim JH, Kim JR, Kang SW, et al. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 2013;155:743-49.
18. Switzer DW Jr., Mendonca LS, Saito M, et al. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration. Retina 2012;32:1265-71.
19. Marsiglia M, Boddu S, Bearelly S, et al. Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration. Invest Ophthalmol Vis Sci 2013;54:7362-9.
20. Rofagha S, Bhisitkul RB, Boyer DS, et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 2013;120:2292-9.